You are here

Anticancer therapies

Combat team: A dendritic cell (right) and a T cell, both from a mouse with skin cancer, combined using the BiCE antibody (yellow)

A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...

Tissue sample of a particularly aggressive skin cancer reveals immune cells (yellow) that express on their surfaces a “brake pedal” receptor called FcgIIb (purple); cell nuclei are in blue

Sometimes anticancer antibodies press on the gas and the brakes at the same time. New research might help them accelerate better

Collagen fibers deposited by fibroblasts in the tumor microenvironment, viewed under a microscope. The fibers form an orderly pattern in tumors with an unmutated BRCA gene (top); in contrast, in tumors of patients harboring BRCA mutations (bottom), the collagen structure is disordered

Weizmann Institute scientists have discovered how mutations in the BRCA genes, particularly prevalent among Ashkenazi Jews, lead to...


How tumors mutate their way out of a crisis – and become drug resistant in the process

Natural anticancer antibodies (green) bound to a single ovarian tumor cell; the cell’s nucleus is in blue. Viewed with confocal microscopy

Natural antibodies found in tumors could point the way toward improved immunotherapy 


A particularly “sticky” molecule could lead to the development of an effective treatment for cancer

Prof. Yardena Samuels

Off-the-shelf therapies to be developed for entire groups of patients

Soma Ghosh

"We attain higher achievement, better results and the opportunity to advance our scientific careers"

Kill the Messenger

A molecule developed at the Institute can intercept potentially cancer-promoting messages before they reach the cell nucleus

Kill the Messenger

A small molecule developed at the Weizmann Institute prevents a cancer-causing message from entering the cell nucleus